NEPTUNE TECH & BIORESRCS (SMCAP: NEPT)





$1.95 -0.01 (-0.51%)
Turn On
KEY STATS
52-Week High Price
2.70
52-Week Low Price
0.41
Avg Volume (3 Mo.)
0.00 M
Market Cap
0.07 B
P/E Ratio (TTM)
0.0
Diluted EPS (TTM)
-0.03
Shares
37.68 M
Dividend Rate ($) / (%)
0.00/0.10
100%
0%
You need to upgrade your Flash Player to view the graph.
View by Date Range:
12 Mo. Price Change : 138% - NEPT has outperformed the S&P 500 by 112%
SIMILAR COMPANIES
NameCurrent Price - Today's ChangeMarket Cap
ZIOPHARM ONCOLOGY INC (ZIOP) $3.09 -  $0.01(0.32%)0.08 B
AMICUS THERAPEUTICS INC (FOLD) $3.49 -  $0.05(1.45%)0.08 B
CERUS CORPORATION (CERS) $2.11 -  $0.09(4.46%)0.08 B
BIOSANTE PHARMACEUTICALS (BPAX) $1.50 -  $0.06(4.17%)0.08 B
OXIGENE INC (OXGN) $1.30 -  $0.06(4.84%)0.08 B
HELICOS BIOSCIENCES CORP (HLCS) $1.00 -  $0.01(0.99%)0.07 B
MANNATECH INC (MTEX) $2.87 -  $0.08(2.87%)0.08 B
ANIKA THERAPEUTICS INC (ANIK) $6.49 -  $0.09(1.41%)0.07 B
BIODELIV SCIENCES INTL (BDSI) $3.52 -  $0.04(1.15%)0.07 B
JAVELIN PHARMACEUT INC (JAV) $1.17 -  $0.02(1.74%)0.08 B
STOCK ANALYSIS
There are currently no Stock Analysis.
NEPT RELATED HEADLINES
arrow
Neptune Technologies & Bioressources Reports Third Quarter Results
Neptune Technologies & Bioressources Reports Third Quarter Results

by GlobeNewswire 1/14/2010
arrow
Neptune Technologies & Bioressources Reports on Additional Preclinical Research Results of Drug Candidate CaPre(TM) Improvement of Glucose Tolerance
Neptune Technologies & Bioressources Reports on Additional Preclinical Research Results of Drug Candidate CaPre(TM) Improvement of Glucose Tolerance

by GlobeNewswire 12/16/2009
arrow
Neptune Reports Third Quarter Sales Estimate and Business Update
Neptune Reports Third Quarter Sales Estimate and Business Update

by GlobeNewswire 12/15/2009
arrow
Neptune Technologies & Bioressources Inc. Reports on Medical Food Candidate Preclinical Research; Pilot ADHD Effect is Confirmed
Neptune Technologies & Bioressources Inc. Reports on Medical Food Candidate Preclinical Research; Pilot ADHD Effect is Confirmed

by GlobeNewswire 11/17/2009
arrow
Neptune Technologies & Bioressources Inc. Has Filed a Patent Infringement Lawsuit Against Aker Biomarine ASA, Jedwards International Inc. and Virgin Antarctic LLC
Neptune Technologies & Bioressources Inc. Has Filed a Patent Infringement Lawsuit Against Aker Biomarine ASA, Jedwards International Inc. and Virgin Antarctic LLC

by GlobeNewswire 11/13/2009
arrow
Neptune Technologies & Bioressources Inc. Reports on Active Pharmaceutical Ingredient (API) Preclinical Research; Significant HDL Increase Confirmed
Neptune Technologies & Bioressources Inc. Reports on Active Pharmaceutical Ingredient (API) Preclinical Research; Significant HDL Increase Confirmed

by GlobeNewswire 11/5/2009
Stock Simulator- Free Account
Chart Advisor- Free Report
Sponsored Links
COLOSIM1